We are live on ! Find out more
BPMC

Blueprint Medicines
BPMC

Delisted

BPMC was delisted on the 17th of July, 2025.

Back to rankings

220 hedge funds and large institutions have $4.68B invested in Blueprint Medicines in 2019 Q2 according to their latest regulatory filings, with 54 funds opening new positions, 94 increasing their positions, 46 reducing their positions, and 34 closing their positions.

New
Increased
Maintained
Reduced
Closed

104% more repeat investments, than reductions

Existing positions increased: 94 | Existing positions reduced: 46

59% more first-time investments, than exits

New positions opened: 54 | Existing positions closed: 34

59% more call options, than puts

Call options by funds: $63.8M | Put options by funds: $40.2M

20% more capital invested

Capital invested by funds: $3.89B → $4.68B (+$792M)

8% more funds holding

Funds holding: 203 → 220 (+17)

8.55% less ownership

Funds ownership: 110.07% → 101.52% (-8.5%)

27% less funds holding in top 10

Funds holding in top 10: 11 → 8 (-3)

Holders
220
Holders Change
+17
Holders Change %
+8.37%
% of All Funds
4.78%
Holding in Top 10
8
Holding in Top 10 Change
-3
Holding in Top 10 Change %
-27.27%
% of All Funds
0.17%
New
54
Increased
94
Reduced
46
Closed
34
Calls
$63.8M
Puts
$40.2M
Net Calls
+$23.6M
Net Calls Change
+$25.6M

Top Buyers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
+$148M
2
BlackRock
BlackRock
New York
+$58.6M
3
HM
HealthCor Management
New York
+$31.6M
4
CCM
Cadian Capital Management
New York
+$26.7M
5
Vanguard Group
Vanguard Group
Pennsylvania
+$26.6M

Top Sellers

Rank Fund Capital Flow
1
PHS
PFM Health Sciences
California
-$77.2M
2
TGI
TRV GP II
Massachusetts
-$70.4M
3
MWNA
Marshall Wace North America
New York
-$21.1M
4
LCM
Laurion Capital Management
New York
-$21M
5
CH
CVI Holdings
Delaware
-$16M
Name Holding Trade Value Shares
Change 		Change in
Stake
1832 Asset Management
101
1832 Asset Management
Ontario, Canada
$2.24M +$1.99M +24,100 New
Voloridge Investment Management
102
Voloridge Investment Management
Florida
$2.21M +$1.94M +23,450 New
Legal & General Group
103
Legal & General Group
United Kingdom
$2.19M +$248K +3,007 +15%
AWM
104
Avitas Wealth Management
California
$2.12M +$1.85M +22,433 New
CI
105
Cowen Inc
New York
$2.08M -$990K -12,000 -35%
Ohio Public Employees Retirement System (OPERS)
106
Ohio Public Employees Retirement System (OPERS)
Ohio
$2.07M +$1.81M +21,977 New
MIM
107
MetLife Investment Management
New Jersey
$2.05M +$327K +3,965 +22%
Los Angeles Capital Management
108
Los Angeles Capital Management
California
$2.01M +$282K +3,415 +19%
Squarepoint
109
Squarepoint
New York
$1.95M -$1.17M -14,224 -41%
AI
110
Axiom Investors
Connecticut
$1.92M +$341K +4,130 +25%
Bank of Montreal
111
Bank of Montreal
Ontario, Canada
$1.89M +$225K +2,722 +16%
Royal Bank of Canada
112
Royal Bank of Canada
Ontario, Canada
$1.88M -$700K -8,481 -30%
Russell Investments Group
113
Russell Investments Group
United Kingdom
$1.85M -$296K -3,590 -15%
Prudential Financial
114
Prudential Financial
New Jersey
$1.8M +$860K +10,421 +120%
ProShare Advisors
115
ProShare Advisors
Maryland
$1.8M -$36K -436 -2%
IBT
116
International Biotechnology Trust
United Kingdom
$1.6M +$1.4M +17,000 New
FP
117
Foundry Partners
Minnesota
$1.53M -$3.88K -47 -0.3%
OAM
118
Oxford Asset Management
United Kingdom
$1.48M +$1.29M +15,673 New
BG
119
Bellevue Group
Switzerland
$1.46M +$1.28M +15,500 New
MLICM
120
Metropolitan Life Insurance Company (MetLife)
New York
$1.4M +$130K +1,578 +12%
PL
121
Polianta Ltd
Jersey
$1.29M +$1.13M +13,700 New
F
122
F3Logic
Minnesota
$1.28M -$413K -5,000 -27%
Principal Financial Group
123
Principal Financial Group
Iowa
$1.22M +$42.8K +519 +4%
Nomura Holdings
124
Nomura Holdings
Japan
$1.21M +$1.03M +12,500 New
PIM
125
Platinum Investment Management
Australia
$1.2M – – –
3 4
5
6 7

BPMC Hedge Fund Activity: Q2 2019 in Review

220 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Blueprint Medicines (BPMC) for Q2 2019, worth a combined $4.68B — up 20% from $3.89B a quarter earlier.

Buyers outnumbered sellers: 54 funds opened new BPMC positions and 34 closed out — a net gain of 20 holders — while 94 added to existing stakes and 46 trimmed.

The largest buyer was Invesco, adding an estimated $148M. The largest seller was PFM Health Sciences, exiting entirely with an estimated $77.2M sold.

  • 220 institutional investors held Blueprint Medicines (BPMC) as of Q2 2019, up from 203 in Q1 2019.
  • Funds reported $4.68B of Blueprint Medicines stock for Q2 2019, up 20% quarter-over-quarter.
  • 54 funds opened new Blueprint Medicines positions in Q2 2019 and 34 closed out, a net change of +20 holders.
  • The largest Blueprint Medicines buyer in Q2 2019 was Invesco, an estimated $148M added.
  • The largest Blueprint Medicines seller in Q2 2019 was PFM Health Sciences, an estimated $77.2M sold.

Based on aggregated 13F filings for Q2 2019.